Follow-up for patients with intestinal metaplasia restricted to the antrum
dc.authorid | Yeşim Saliha Gürbüz / 0000-0002-4278-8241 | en_US |
dc.authorscopusid | Yeşim Saliha Gürbüz / 7004052030 | |
dc.authorwosid | Yeşim Saliha Gürbüz / CRQ-9252-2022 | |
dc.contributor.author | Koç, Deniz Öğütmen | |
dc.contributor.author | Hülagü, Sadettin | |
dc.contributor.author | Gürbüz, Yeşim Saliha | |
dc.contributor.author | Çelebi, Altay | |
dc.contributor.author | Duman, Ali Erkan | |
dc.contributor.author | Kazaz, Tanyeli Güneyligil | |
dc.date.accessioned | 2021-01-25T07:04:23Z | |
dc.date.available | 2021-01-25T07:04:23Z | |
dc.date.issued | 2020 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Objective: Guidelines recommend endoscopic surveillance for patients with extensive atrophy/intestinal metaplasia (IM), but follow-up is not recommended for patients with atrophy/IM restricted to the antrum. We evaluated the risk of neoplastic lesions in patients with antrum-restricted IM to determine whether surveillance endoscopy is necessary. Methods: Overall, 117 patients with antrum-restricted IM diagnosed within the past 10 years underwent surveillance endoscopy. The gastric biopsy specimens were evaluated for atrophy, IM, and dysplasia. Results: We enrolled 117 patients. Surveillance endoscopy was performed at a median (interquartile range) of 7.2 years (5.9-8.7 years) after the initial diagnosis of IM. On surveillance endoscopy, 27.4% of patients exhibited progression in their IM grade, whereas 25.6% had atrophy progression, and 33.3% had dysplasia progression. High-grade dysplasia and gastric cancer (GC) were detected in four and two patients, respectively. The annual incidence of GC in patients with antrum-restricted IM was 0.17%. IM grade and type regressed in 29.9% and 38.5% of patients, respectively. Most patients with progressive IM grade, IM type, and dysplasia on surveillance endoscopy had Operative Link on Gastritis Assessment (OLGA) stage 3-4 (p=0.0001, p=0.008, and p=0.0001, respectively), and most patients with progressive atrophy and dysplasia had Operative Link on Gastric IM (OLGIM) stage 3-4 (both p=0.001). Conclusion: Patients with IM restricted to the antrum are at risk for neoplastic lesions and require endoscopic surveillance, contrary to existing recommendations. Premalignant lesions can exhibit both progression and regression. Therefore, a patient-specific surveillance program based on OLGA and OLGIM might be appropriate. | en_US |
dc.identifier.citation | Koç, D. Ö., Hülagü, S., Gürbüz, Y. S., Çelebi, A., Duman, A. E., & Kazaz, T. G. (2020). Follow-up for Patients with Intestinal Metaplasia Restricted to the Antrum. Journal of Academic Research in Medicine, 10(3). | en_US |
dc.identifier.doi | 10.4274/jarem.galenos.2020.3885 | en_US |
dc.identifier.endpage | 276 | en_US |
dc.identifier.issn | 2146-6505 | en_US |
dc.identifier.issn | 2147-1894 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 269 | en_US |
dc.identifier.trdizinid | 417170 | en_US |
dc.identifier.uri | https://doi.org/10.4274/jarem.galenos.2020.3885 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/1363 | |
dc.identifier.volume | 10 | en_US |
dc.identifier.wos | WOS:000604280800012 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.institutionauthor | Gürbüz, Yeşim Saliha | |
dc.language.iso | en | en_US |
dc.publisher | GALENOS YAYINCILIK | en_US |
dc.relation.ispartof | JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Gastric Cancer | en_US |
dc.subject | Intestinal Metaplasia | en_US |
dc.subject | Surveillance Endoscopy | en_US |
dc.title | Follow-up for patients with intestinal metaplasia restricted to the antrum | en_US |
dc.type | Article | en_US |